Status:
COMPLETED
Clinical Validation of Nutritional Supplements Developed for Pancreaticobiliary Cancer Patients
Lead Sponsor:
Yonsei University
Conditions:
Pancreaticobiliary Cancer
Eligibility:
All Genders
19-80 years
Phase:
NA
Brief Summary
Decreased bowel function and loss of appetite in patients who underwent pancreaticobiliary surgery contribute impaired nutritional status in postoperative period. It can also affect perioperative and ...
Eligibility Criteria
Inclusion
- Adult (age more than 19)
- Pancreaticobiliary cancer patient who is scheduled pancreaticoduodenectomy or distal pancreatectomy
- Pancreatic cancer / Duodenal cancer / Distal bile duct cancer / Ampulla of Vater cancer
Exclusion
- Patient who denied clinical trial
- Diabetes Mellitus(DM) patient with DM complication
- Hyperlipidemia patient with vascular co-morbidity
- Impaired renal function or renal failure (GFP\<70%)
- Poor nutritional status (PG-SGA grade C)
Key Trial Info
Start Date :
September 4 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 11 2018
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT03294096
Start Date
September 4 2017
End Date
July 11 2018
Last Update
January 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Yonsei University College of Medicine
Seoul, South Korea, 03722